{"id":"W4401199280","doi":"10.1136/bmjopen-2023-083691","title":"Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias – pilot study protocol","year":2024,"lang":"en","type":"article","venue":"BMJ Open","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network","funders":"Third Health Programme; European Commission; Agios Pharmaceuticals","keywords":"Medicine; Protocol (science); Clinical trial; Pilot trial; Protocol design; Research design; Medical physics; Randomized controlled trial; Alternative medicine; Surgery; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005078069,0.00026559,0.001622663,0.0002364201,0.00007539081,0.00008805937,0.0002215829,0.0001566743,0.0001628622],"category_scores_gemma":[0.01131013,0.0001870833,0.0003661148,0.0003233313,0.00009755584,0.0002098729,0.0001291,0.0002660182,0.000004212499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007673848,"about_ca_system_score_gemma":0.0005074927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002472287,"about_ca_topic_score_gemma":0.0001039697,"domain_scores_codex":[0.995586,0.0009582025,0.002229138,0.0006157095,0.0003395615,0.0002714108],"domain_scores_gemma":[0.9944906,0.003821927,0.0006607357,0.0003729352,0.0005447227,0.0001090456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9450839,0.02914527,0.00302788,0.002292331,0.0006037073,0.00003235271,0.0006571614,0.000004623273,0.0004508513,0.0006798442,0.002434383,0.01558769],"study_design_scores_gemma":[0.5374987,0.4469689,0.001672192,0.00635373,0.0005178442,0.000007383381,0.001032952,0.0002638989,0.001284861,0.00235187,0.001691355,0.0003563148],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.2665096,0.00001335614,0.02267678,0.0003611466,0.0009529173,0.7091386,0.0001826634,0.00005737404,0.0001074826],"genre_scores_gemma":[0.3076475,0.000001082873,0.04206674,0.000421738,0.0008448381,0.6485287,0.0001988397,0.000073255,0.0002173252],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.4178236,"threshold_uncertainty_score":0.997018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.341661158231077,"score_gpt":0.5316405115425945,"score_spread":0.1899793533115176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}